**AI生物科学初创公司Bioptimus获3500万美元种子轮融资**
法国人工智能新秀Bioptimus在成立不久后便成功吸引了业界的广泛关注，近日，该公司宣布完成了一笔3500万美元的种子轮融资。Bioptimus致力于利用人工智能技术为生物技术领域构建一个大规模的语言模型，旨在革新生物科技的研究与开发。
本轮融资由法国知名生命科学风险投资公司Sofinnova Partners和公共银行Bpifrance Large Ventures联合领投，彰显了投资者对Bioptimus前景的强烈信心。此外，法国风险投资公司Frst、国际投资机构Cathay Innovation，以及美国投资者Headline和Owkin也纷纷加入投资阵容。值得一提的是，法国亿万富翁企业家Xavier Niel也积极参与了本次融资，他的加入为Bioptimus的发展注入了更多动力。
Bioptimus的这一创举不仅展示了人工智能在生物科学领域的广阔应用潜力，也反映出投资者对AI驱动的生物科技初创公司的浓厚兴趣。此轮融资的资金将主要用于加速Bioptimus的研发进程，构建更强大的AI模型，以及拓展其在全球生物技术市场的影响力。
据消息来源Sifted报道，Bioptimus的快速崛起和成功融资，预示着AI技术在生物科技行业的深度融合将可能带来革命性的突破，有望为未来的医疗和健康解决方案开辟新的道路。
英语如下：
**AI Biotech Startup Bioptimus Raises $35M Seed Funding to Develop AI Language Models for Biology**
Keywords: Bioptimus, seed round, $35 million
News Content:
**French AI biotech Bioptimus secures $35 million seed investment**
Fresh on the scene, French artificial intelligence (AI) upstart Bioptimus has garnered significant industry attention and recently announced a $35 million seed funding round. The company aims to revolutionize biotechnology research and development by leveraging AI to build a large-scale language model for the field.
The financing round was co-led by prominent life sciences venture capital firm Sofinnova Partners and public bank Bpifrance Large Ventures, indicating strong investor confidence in Bioptimus’s future. Notable participants also include French VC firm Frst, international investor Cathay Innovation, and American investors Headline and Owkin. It’s worth mentioning that French billionaire entrepreneur Xavier Niel also joined the funding round, adding further momentum to Bioptimus’s growth.
Bioptimus’s endeavor highlights the vast potential of AI in the biological sciences and reflects the mounting interest in AI-driven biotech startups. The funds raised will primarily be used to accelerate the company’s R&D, develop more robust AI models, and expand its global footprint in the biotechnology market.
According to Sifted, Bioptimus’s rapid ascent and successful fundraising signal a potential game-changing integration of AI in the biotech industry, potentially paving the way for groundbreaking advancements in medical and health solutions.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 1